About SPRIM

From a single consulting firm in 2001 to a brand shared by two companies today.

SPRIM was founded in 2001 as a life‑science consulting and CRO firm. Over the next fifteen years it worked with biotech, medtech, pharmaceutical and consumer healthcare companies across the Americas, Europe and Asia‑Pacific; building a reputation for rigour at the boundary of science and commerce.

Following a 2015 divestment and reorganisation, the SPRIM name became shared by two specialised companies. SPRIM Global Investments, headquartered in Singapore, deploys strategic capital into clinical‑stage innovation. SPRIM Health Group, headquartered in Europe, provides integrated medical, marketing and commercial consulting.

What we share

Principles that bind SGI and SHG.

01

Operator‑led.

We have sat on the other side of the table.

SPRIM was built by people who have run trials, launched products and scaled healthcare businesses. That operator vantage point shapes how SGI invests and how SHG consults – practical, specific, grounded.

02

Domain depth.

Healthcare, and only healthcare.

Across pharma, biotech, medtech, digital health, consumer healthcare and medical nutrition, a quarter century of focus means specialists, not generalists.

03

Independent by design.

Two firms, kept separate on purpose.

Investment and consulting work belong in separate hands – for clarity, for governance, for our clients and partners. The shared brand is a guarantee of standards.

History

25 years of SPRIM.

2001

Founded

SPRIM established as a global life‑science consulting and CRO firm.
“Santé, Prévention, Recherche, Innovation Médicale”

2005

First international expansion

After openings in Europe and the Americas, offices opened in Asia.

2008

Three‑continent footprint

Operations established across the Americas and Asia‑Pacific. Network spans 18+ cities.

2012

Specialised verticals form

Distinct practices emerge: medical excellence, marketing impact, commercial success, and capital deployment.

2015

Divestment & reorganisation

Strategic exits and divestitures. SPRIM brand re‑architected to be shared by two specialised companies.

2018

SGI launches investment platform

SPRIM Global Investments formalised in Singapore – life‑science investment firm with operator DNA.

2020

SHG consolidates European footprint

SPRIM Health Group operating across Madrid, Milan, London, Paris, Lisbon and Berlin.

2023

SGI expands investment activities

Launch of TrialCap, SGI’s dedicated platform for structured clinical trial financing across global markets.

Today

One brand, two firms

sprim.com becomes the shared front door for the SPRIM brand, the history, and both companies.

Leadership

Combined leadership across both firms.

SPRIM Global Investments

SGI · Singapore

Dr. Michael Shleifer

Dr. Michael Shleifer

Co-Founder, Managing Partner

Michael is a healthcare entrepreneur with PhDs and Masters degrees from Paris V and Sciences Po. He co-founded SPRIM in 2001 – now a 700-person, 17-country consulting and CRO firm – and in 2015 launched SPRIM Global Investments to fund late-stage biotech and tech-enabled clinical trial companies.

More about Michael
Thomas Fratacci

Thomas Fratacci

Chief Financial Officer

Thomas is Group CFO of SPRIM and SPRIM Ventures, overseeing all finance functions and business modelling for funding rounds. With 20 years of experience in corporate finance, his background includes financial audit at Arthur Andersen and KPMG, and 8 years at WPP/Kantar. He holds a Masters from EDHEC.

More about Thomas
Ivan Jarry

Ivan Jarry

Co-founder

Ivan Jarry is Co-Founder and Managing Partner of SPRIM, where since 2001 he has led global operations and opened offices across Asia, the Americas, and beyond. In 2015 he co-founded SPRIM Ventures. He holds an MBA from EDHEC Paris.

More about Ivan

SPRIM Health Group

SHG · Europe

Olivier Shleifer

Olivier Shleifer

Co-Founder, Managing Partner

Olivier Shleifer is Co-Founder and Managing Partner of SPRIM Health Group, a 500+ person global health consultancy. Since 2001 he has focused on health innovation solutions, and also teaches entrepreneurship at ESCP Business School and innovation at Universidad Complutense de Madrid. He holds a degree from ESCP.

More about Olivier

LOCATIONS

Our Head Offices

SGI

Singapore

79 Science Park Drive Level 06 Unit 01/08
CINTECH IV, Science Park 1, Singapore – 118264

SHG

Madrid

C / Hermosilla, 46
28001 Madrid Spain